Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-485-8 | CAS number: 822-06-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- traditional method
- Limit test:
- no
Test material
- Reference substance name:
- Hexamethylene diisocyanate
- EC Number:
- 212-485-8
- EC Name:
- Hexamethylene diisocyanate
- Cas Number:
- 822-06-0
- Molecular formula:
- C8H12N2O2
- IUPAC Name:
- 1,6-diisocyanatohexane
- Reference substance name:
- Desmodur H
- IUPAC Name:
- Desmodur H
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa Credo (Brussels, Belgium)
- Strain: Wistar, ICO:WU (IOPS CPB)
- Age at study initiation: 2-3 months
- Weight at study initiation: males: 173-209 g; females: 164-189 g
- Housing: individual
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): approx. 50
- Air changes (per hr): approx. 10
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: aluminium inhalation chamber (two-chamber system)
- Exposure chamber volume: about 3.8 l
- Method of holding animals in test chamber: Plexiglas exposure tubes applying a directed-flow nose-only exposure principle
- Source and rate of air: compressed air was supplied by Boge compressors; > 236 air exchanges per hour
- Method of conditioning air: air was conditioned (i.e. freed from water, dust, and oil) automatically by a VIA compressed air dryer
- Method of particle size determination: samples for the analysis of the aerodynamic particle-size distribution were taken in the vicinity of the breathing zone. The primary objective of these measurements, however, was to determine whether a condensation aerosol would occur. These samples were taken using a TSl-Laser Velocimeter APS 3300, including diluter TSI Model 3302 (TSI Inc., St. Paul, MN, USA). Particle size measurements were conducted once per exposure.
- Treatment of exhaust air: the exhaust air was purified via glass bubbler containing 10% aqueous NaOH solution and passed through cotton-wool/activated charcoal and HEPA filters. These filters were disposed of by Bayer AG.
- Temperature, humidity in air chamber: temperature and humidity measurements are also performed by the computerized HP 3852A
Data Acquisition and Control System using FTFI I sensors (ELKA ELEKTRONIK, Lüdenscheid, Germany) The position of the measuring probe was at the exhaust location. Temperature and humidity data are integrated for 30-seconds and displayed accordingly. The hurnidity sensors are calibrated using saturated salt solutions according to Greenspan (1977) and Pauluhn (1994) in a two-point calibration at 33% (MgCh) and at 75% (NaCl) relative humiduy The calibration of the temperature sensors is also checked at two temperatures using reference thermometers.
TEST ATMOSPHERE
- Brief description of analytical method used: the nominal concentration was calculated taking into account the actually evaporated mass of test substance (difference of weight of the glass bubbler before and after exposure) devided by total airflow through the chamber. The test atmosphere was determined by HPLC after derivatization of the isocyanate functionality. Samples were taken by using glass powder filled tubes containing nitroreagent as scavenging agent.
- Samples taken from breathing zone: yes
RESULTS OF PARTICLE-SIZE ANALYSES
- In the 55, 107, 120 and 151 mg/m3 exposure groups, the total mass of aerosol detected was 0.4, 6.3, 13.8 and 21.3 mg/m3, resp. based on CMAD calculation.
- Particle size distribution: In the 55, 107, 120 and 151 mg/m3 exposure groups 51, 64, 67 and 71 % ,resp. of particles were < 3 µm.
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): In the 55, 107, 120 and 151 mg/m3 exposure groups MMAD was 2.98, 2.54, 2.46 and 2.34 µm, resp. (GSD: 1.75, 1.60, 1.60 and 1.60, resp.). - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- analytical concentrations: 0, 55, 107, 120, 151 mg/m3;
nominal concentrations: 0, 64, 114, 153, 169 mg/m3 - No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 28 days
- Frequency of observations and weighing: clinical signs were examined several times on the day of exposure and twice daily therafter; body weights were measured before exposure, on days 3 and 7, and weekly thereafter.
- Necropsy of survivors performed: yes
- Other examinations performed: rectal temperature - Statistics:
- -Necropsy flndings: If specific findings occur from the respiratory tract of surviving rats they are evaluated statistically using the pairwise Fisher test after the R x C chi-squared test.
-Body weights: Means and single standard deviations of body weights are calculated. Since in acute studies individual group means may differ prior to commencement of the first exposure, the body weight gain was statistically evaluated for each group. For these evaluations a one-way ANOVA (vide infra) is used.
-Calculation of the LC50: If calculation of a median lethal concentration (LC50) is possible, it is performed by computer (HP 3000) according to the method of AP. Rosiello, I.M. Essigmann, and G.N. Wogan (1977) as modified by Pauluhn (1983). This method is based on the maximurn-likelihood method of C.I. Bliss (1938). If only 2 pairs of values with greater than 0% lethality and less than 100% are available then the first linear approximation is based on these values and a homogeneity test is not performed. The interpolated concentration at 50% lethality in this case was designated at approximate LC50.
-Analysis of variance (ANOVA): This parametric method checks for normal distribution of data by comparing the median and mean The groups are compared at a confidence level of (1-alpha)= 95% (p=0.05) The test for the between-group homogeneity of the variance employed Box's test if more than 2 study groups were compared with each other. If the above F-test shows that the intra-group variability is greater than the inter-group variability, this is shown as "no statistical difference between the groups". If a difference is found then a pairwise post-hoc comparison is conducted (1- and 2-sided) using the Games and Howell modification of the Tukey-Kramer significance test.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 124 mg/m³ air
- 95% CL:
- >= 111 - <= 140
- Exp. duration:
- 4 h
- Remarks on result:
- other: NOAEL: < 55 mg/m3 air
- Mortality:
- Exposure to vapour concentrations of 55 mg/m3 did not induce test substance related mortality. Exposure to 107 mg/m3 air and above was followed by a characteristic type of mortality pattern occurring within post exposure days 1 through 6. Marked gender specific differences in susceptibility was not observed (details see table 1).
- Clinical signs:
- other: see "Other findings"
- Body weight:
- Decreased body weights were observed in all groups exposed to the test compound (at 55 mg/m3 and above).
- Gross pathology:
- Gross necropsy (among others) revealed less collapsed, discolorated (dark-red) lungs with serous mucus in the trachea. The lung associated lymph nodes were enlarged.
- Other findings:
- All animals showed normal reflexes. One rat of group 5 (151 mg/m3) showed mildly changed reflexes due to its moribund state.
Concentration-dependent effect on body temperature were observed at 55 mg/m3 and above (details see table 1).
Clinical Signs:
Exposures to concentrations of 55 mg/m3 and above were followed by concentration-dependent signs indicative of respiratory tract irritation, suchas bradypnea, dyspnea, laboured breathing pattern, rales, nostril/snout area with red encrustations, cyanosis, prostration (lying on belly), reduced motility, ungroomed haircoat, hypothermia, decrease in body weights, and piloerection. The duration of signs (maximum duration up to day 28) and, in most instances, was dependent on respiratory signs (see also table 1 for onset and duration of signs).
Any other information on results incl. tables
Table 1: Acute inhalation toxicity (vapour) of HDI
Sex | Analytical concentration (mg/m3) | Toxicological results | Onset and duration of signs | Rectal temperature(°C) | Onset of mortality |
male | 0 | 0 / 0 / 5 | --- | 38.0 | --- |
55 | 0 / 5 / 5 | 0d - 8d | 30.7 * | --- | |
107 | 2 / 5 / 5 | 0d - 28d | 30.2 * | 1d | |
120 | 1 / 5 / 5 | 0d - 28d | 28.2 * | 2d | |
151 | 5 / 5 / 5 | 0d - 2d | 28.1 * | 1d - 3d | |
female |
0 | 0 / 0 / 5 | --- | 38.4 | --- |
55 | 0 / 5 / 5 | 0d - 7d | 31.2 * | --- | |
107 | 1 / 5 / 5 | 0d - 14d | 29.6 * | 2d | |
120 | 3 / 5 / 5 | 0d - 28d | 28.2 * | 2d - 4d | |
151 | 3 / 5 / 5 | 0d - 28d | 27.6 * | 3d - 6d |
Toxicological results:
number of dead animals / number of animals with signs after cessation of exposure / number of animals exposed
* p<0.01 (Tukey-Kramer post hoc test)
Applicant's summary and conclusion
- Executive summary:
Exposure to vapour concentrations of 55 mg/m3 did not induce test substance related mortality. Exposure to 107 mg/m3 air and above was followed by a characteristic type of mortality pattern occurring within post exposure days 1 through 6. Marked gender specific differences in susceptibility could not be observed. Exposures to concentrations of 55 mg/m3 and above were followed by a concentration-dependent signs indicative of respiratory tract irritation, such as bradypnea, dyspnea, laboured breathing pattern, rales, nostrils/muzzle with red encrustations, cyanosis, prostration (lying on belly), reduced motility, ungroomed haircoat, hypothermia, decreased body weights, and piloerection. The duration of signs (maximum duration up to day 28), in most instances, was dependent on respiratory signs. Gross necropsy (among others) revealed less collapsed, discolorated (dark-red) lungs with serous mucus in trachea. The lung associated lymph nodes were enlarged. Clinical observations and necropsy findings support the conclusion that a causal relationship between lethality and lung damage existed.
The evaporated test substance proved to have a high acute inhalation toxicity to rats (LC50 - vapour, 4 h: 124 mg/m3 air). Cumulative evidence suggest that there is a causal relationship of local effects to the respiratory tract and the observed findings.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.